Palbociclib dihydrochloride
Ref. TM-T63634
25mg | 1,418.00 € | ||
50mg | 1,846.00 € | ||
100mg | 2,331.00 € |
Product Information
Palbociclib, oral CDK4/6 inhibitor (IC50: 11/16 nM), targets HR+/HER2- breast cancer and hepatocellular carcinoma.
Chemical properties
Technical inquiry about: TM-T63634 Palbociclib dihydrochloride
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.